Trusted Resources: Education
Scientific literature and patient education texts
Understanding Mucopolysaccharidosis Type VII (MPS VII) or Sly Syndrome
source: Ultragenyx Pharmaceutical Inc.
year: N/A
summary/abstract:MPS VII, also called Sly syndrome, is a rare, life-threatening lysosomal storage disorder, caused by mutations of the GUSB gene, which results in a deficiency of the β-glucuronidase enzyme. β-glucuronidase plays a key role in the breakdown of glycosaminoglycans (GAGs), previously called mucopolysaccharides. The inability to properly break down GAGs causes them to build up in the lysosomes.
Signs and symptoms of MPS VII generally become more severe. Hip dysplasia and worsening pulmonary function are two of the progressive symptoms commonly observed in patients with MPS VII. In some cases, people with MPS VII may develop new signs and symptoms, which may also progress. It is important to recognize the signs and symptoms of MPS VII. Early and accurate diagnosis and management may help to slow disease progression.
read more
Related Content
-
Airway Management of the Deformed Trachea Using T-Tube Stents in Patients With Mucopolysaccharidosis Type IVAIntroduction: Mucopolysaccharidosis (MPS...
-
Therapy-Type Related Long-Term Outcomes in Mucopolysaccaridosis Type II (Hunter Syndrome) – Case SeriesMucopolysaccharidosis type II (MPS II, H...
-
A Guide to Understanding MPS IV (Morquio Syndrome)Mucopolysaccharidosis IV (MPS IV) is a r...
-
Sanfilippo Ideal for FDA’s Accelerated Approval Pathway, Foundation SaysThe Cure Sanfilippo Foundation is encour...
-
Elizabeth F. Neufeld, PhDBorn in France, Elizabeth Neufeld immigr...
-
Mucopolysaccharidosis III: Molecular Basis and TreatmentMucopolysaccharidoses (MPSs) are known a...
-
Beverly L. Davidson, PhDBeverly L. Davidson, PhD, is Director of...